Tag:

Zoetis

Latest Headlines

Latest Headlines

Zoetis unloading India plant to Zydus as it continues its cost cutting

The world's largest animal health company is moving forward with its pledge to become a little less large. In its second deal in two weeks, Zoetis will sell a production site and some of its products in India to Zydus Cadila as part of its pledge to close 10 plants and cut about 2,500 employees as it strives to improve margins.

Cadila to buy Zoetis animal drugs and feed plant in India for $29M

Cadila Healthcare is buying the Zoetis manufacturing site in Haridwar for about $29 million in a deal that will give the India drugmaker production facilities for medicated feed additives, anti-infectives, parasiticides and nutritionals for livestock.

Zoetis hives off 3 manufacturing plants in deal with Bulgarian drugmaker

Zoetis, under pressure from investors to shape up, laid out a sweeping plan earlier this year to eliminate 10 plants and about 2,500 jobs as part of an effort to flush out operating costs and improve its margins. But the animal health leader did not specify at the time which plants would have to go. Now it has provided its first peek at its intentions and it is starting with a three-facility deal with a Bulgarian firm. 

Zoetis selling plants, products to Bulgaria's Huvepharma in $40M deal

Zoetis, under pressure from investors to shape up, laid out a sweeping plan earlier this year to eliminate 10 plants and about 2,500 jobs as part of an effort to flush out operating costs and improve its margins. But the animal health leader did not specify at the time which plants would have to go. Now it has provided its first peek at its intentions and it is starting with a three-facility deal with a Bulgarian firm.

Bayer, coveting top spots in animal and consumer health, may eye deals for Zoetis, Pfizer OTC

Bayer may have a big-time move up its sleeve, Reuters ' sources say--and it could include animal health leader Zoetis or Pfizer's consumer offerings.

Zoetis agrees on $765M deal for aquaculture leader Pharmaq

Animal health leader Zoetis--which has been the subject of many a pharma buyout rumor--is making a pickup of its own. Late Monday, the Pfizer spinoff announced an agreement to purchase Pharmaq--which specializes in vaccines and pharmaceuticals for farmed fish--for $765 million.

Zoetis expands Nebraska facility even as its plots 10 plant closings

Animal health leader Zoetis has said that its massive cost-cutting plans will include whacking 10 unnamed manufacturing sites. But this week its manufacturing unit was taking solace in the expansion of one of its largest facilities.

With vet drugs pumping, it's no wonder that pharma's eyeing M&A

What's with all the M&A rumors floating around in the animal health world? Just look at Zoetis' Apoquel and it's clear why Big Pharma names are keen to bolster their positions in the space.

Valeant can have Zoetis, Bayer says. We have our hands full already

Whether animal health leader Zoetis receives any more buyout offers after Valeant's reported approach remains to be seen. But if it does, Bayer's leaders insist a competing bid won't be coming from them.

Valeant makes offer for Zoetis, sources tell WSJ

Rapidly expanding Valeant has approached Zoetis about a buyout, sources told the Wall Street Journal. Rumors of a possible deal, which have been bouncing back and forth for weeks, set off buying, with Zoetis shares closing up 11% Thursday at an all-time high of $55.38.